Contract facts
FederalNo full NAICS 325413 intel page yet. Browse NAICS intelligence
ANALYZER AND REAGENTS is a federal award for W40m Mrc0 West held by Ortho-Clinical Diagnostics, Inc. Estimated value $520K ($520K obligated). Current period of performance ends Sep 30, 2026. Place of performance: RARITAN NJ. Related solicitation W81K0024Q0033.
Recompete timing
PublicCurrent PoP ends Sep 30, 2026 (40 days remaining). Agencies typically plan 12–18 months ahead — at 1.3 months out, that window is already open. The buying decision is likely already in motion.
Incumbent footprint
Public recordOrtho-Clinical Diagnostics, Inc — $57.6M obligated across 1,615 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract W81K0025FA106?
W81K0025FA106 (Analyzer and reagents) is a W40m Mrc0 West award with a potential value of $520K, currently held by Ortho-Clinical Diagnostics, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded W81K0025FA106?
W40m Mrc0 West awarded W81K0025FA106 to Ortho-Clinical Diagnostics, Inc (potential $520K).
Who is the incumbent on W81K0025FA106?
Ortho-Clinical Diagnostics, Inc is the incumbent with $57.6M across 1615 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2026.
When does Ortho-Clinical Diagnostics, Inc’s W81K0025FA106 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.